"This is the site for Loyola University Health Sciences Campus, NOT the Loyola University Medical Center."

During the past decade, Loyola University Chicago Health Sciences Division conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loyola University Chicago Health Sciences Division" #1 collaborator was "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Loyola University Chicago Health Sciences Division" are "Overactive Bladder" (1 trials) and "Quality of Life" (1 trials). Many other conditions were trialed in "Loyola University Chicago Health Sciences Division" in a lesser frequency.

Most popular intervention types in "Loyola University Chicago Health Sciences Division" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Solifenacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Loyola University Chicago Health Sciences Division" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Loyola University Chicago Health Sciences Division". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Loyola University Chicago Health Sciences Division, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Loyola University Chicago Health Sciences Division, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".